No Data
No Data
Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's Is How to Trade
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Have Been Lifting Their Price Targets
A Quick Look at Today's Ratings for Tarsus Pharmaceuticals(TARS.US), With a Forecast Between $65 to $84
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
Tarsus Pharmaceuticals Is Maintained at Neutral by Goldman Sachs
No Data